421 related articles for article (PubMed ID: 22176478)
21. Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN).
Opheim R; Hoivik ML; Solberg IC; Moum B;
J Crohns Colitis; 2012 Apr; 6(3):345-53. PubMed ID: 22405172
[TBL] [Abstract][Full Text] [Related]
22. Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study.
Oxelmark L; Lindberg A; Löfberg R; Sternby B; Eriksson A; Almer S; Befrits R; Fossum B; Karlén P; Broström O; Tysk C;
Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1320-8. PubMed ID: 27472271
[TBL] [Abstract][Full Text] [Related]
23. Concurrent use of complementary and alternative medicine with antiretroviral therapy reduces adherence to HIV medications.
Ekwunife OI; Oreh C; Ubaka CM
Int J Pharm Pract; 2012 Oct; 20(5):340-3. PubMed ID: 22953773
[TBL] [Abstract][Full Text] [Related]
24. Adherence to medical treatment in inflammatory bowel disease patients.
Zelante A; De Giorgi A; Borgoni R; Trevisani L; Gallerani M
Minerva Gastroenterol Dietol; 2014 Dec; 60(4):269-74. PubMed ID: 25384805
[TBL] [Abstract][Full Text] [Related]
25. Use of Complementary and Alternative Medicine in Inflammatory Bowel Disease Around the World.
Zezos P; Nguyen GC
Gastroenterol Clin North Am; 2017 Dec; 46(4):679-688. PubMed ID: 29173516
[TBL] [Abstract][Full Text] [Related]
26. Cannabis use amongst patients with inflammatory bowel disease.
Lal S; Prasad N; Ryan M; Tangri S; Silverberg MS; Gordon A; Steinhart H
Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):891-6. PubMed ID: 21795981
[TBL] [Abstract][Full Text] [Related]
27. Complementary alternative medicine in patients with inflammatory bowel disease: use and attitudes.
Quattropani C; Ausfeld B; Straumann A; Heer P; Seibold F
Scand J Gastroenterol; 2003 Mar; 38(3):277-82. PubMed ID: 12737442
[TBL] [Abstract][Full Text] [Related]
28. Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis.
Nousiainen P; Merras-Salmio L; Aalto K; Kolho KL
BMC Complement Altern Med; 2014 Apr; 14():124. PubMed ID: 24708564
[TBL] [Abstract][Full Text] [Related]
29. Use and predictors of oral complementary and alternative medicine by patients with inflammatory bowel disease: a population-based, case-control study.
Koning M; Ailabouni R; Gearry RB; Frampton CM; Barclay ML
Inflamm Bowel Dis; 2013; 19(4):767-78. PubMed ID: 23429459
[TBL] [Abstract][Full Text] [Related]
30. Practices and attitudes toward complementary and alternative medicine in inflammatory bowel disease: a survey of gastroenterologists.
Gallinger ZR; Nguyen GC
J Complement Integr Med; 2014 Dec; 11(4):297-303. PubMed ID: 25294717
[TBL] [Abstract][Full Text] [Related]
31. Complementary medicine use by patients with inflammatory bowel disease.
Hilsden RJ; Scott CM; Verhoef MJ
Am J Gastroenterol; 1998 May; 93(5):697-701. PubMed ID: 9625111
[TBL] [Abstract][Full Text] [Related]
32. The who-when-why triangle of CAM use among Portuguese IBD patients.
Portela F; Dias CC; Caldeira P; Cravo M; Deus J; Gonçalves R; Lago P; Morna H; Peixe P; Ramos J; Sousa H; Tavares L; Vasconcelos H; Magro F; Ministro P
Dig Liver Dis; 2017 Apr; 49(4):388-396. PubMed ID: 28117198
[TBL] [Abstract][Full Text] [Related]
33. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
[TBL] [Abstract][Full Text] [Related]
34. Use of complementary and alternative medicine by patients with inflammatory bowel disease.
Hilsden RJ; Verhoef MJ; Rasmussen H; Porcino A; DeBruyn JC
Inflamm Bowel Dis; 2011 Feb; 17(2):655-62. PubMed ID: 20848543
[TBL] [Abstract][Full Text] [Related]
35. The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre.
Chrystal K; Allan S; Forgeson G; Isaacs R
N Z Med J; 2003 Jan; 116(1168):U296. PubMed ID: 12601420
[TBL] [Abstract][Full Text] [Related]
36. Complementary Therapies in Inflammatory Bowel Diseases.
Yanai H; Salomon N; Lahat A
Curr Gastroenterol Rep; 2016 Dec; 18(12):62. PubMed ID: 27747459
[TBL] [Abstract][Full Text] [Related]
37. Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease.
Joos S; Rosemann T; Szecsenyi J; Hahn EG; Willich SN; Brinkhaus B
BMC Complement Altern Med; 2006 May; 6():19. PubMed ID: 16716218
[TBL] [Abstract][Full Text] [Related]
38. Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey.
Langhorst J; Anthonisen IB; Steder-Neukamm U; Lüdtke R; Spahn G; Michalsen A; Dobos GJ
Inflamm Bowel Dis; 2005 Mar; 11(3):287-95. PubMed ID: 15735435
[TBL] [Abstract][Full Text] [Related]
39. Use of complementary and alternative medicine (CAM) in patients with inflammatory bowel disease (IBD): results from a German nationwide survey of 2019 compared to a previous survey of 2002.
Bauer N; Kairey L; Schlee C; Uecker C; Öznur Ö; Langhorst J
Scand J Gastroenterol; 2022 Oct; 57(10):1209-1215. PubMed ID: 35722930
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel disease.
Gröchenig HP; Waldhör T; Haas T; Wenzl H; Steiner P; Koch R; Feichtenschlager T; Eckhardt G; Mayer A; Kirchgatterer A; Ludwiczek O; Platzer R; Papay P; Gartner J; Fuchssteiner H; Miehsler W; Peters PG; Reicht G; Kutschera M; Dejaco C; Vogelsang H; Novacek G;
Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1211-1219. PubMed ID: 31498280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
